VECT HORUS has a total of 26 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DELINIA INC, CELLDEX THERAPEUTICS INC and ABLBIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 4 | |
#4 | United States | 3 | |
#5 | EAPO (Eurasian Patent Organization) | 2 | |
#6 | France | 2 | |
#7 | Hungary | 2 | |
#8 | Canada | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Khrestchatisky Michel | 25 |
#2 | David Marion | 21 |
#3 | Molino Yves | 15 |
#4 | Lecorche Pascaline | 13 |
#5 | Vlieghe Patrick | 11 |
#6 | Jacquot Guillaume | 8 |
#7 | Temsamani Jamal | 5 |
#8 | Nowak Jonathan | 5 |
#9 | Malcor Jd | 4 |
#10 | Payrot Nadine | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020144233A1 | Transferrin receptor-binding molecules, conjugates thereof and their uses | |
WO2018138372A1 | Compositions and methods for cancer imaging and radiotherapy | |
EP2896402A1 | Activated neurotensin molecules and the uses thereof | |
CN105050612A | Compositions and methods for drug delivery | |
FR2959229A1 | Peptide derivatives, their preparation and uses thereof | |
EP2350117A1 | Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |